Eledon Pharmaceuticals In...

NASDAQ: ELDN · Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:48 PM

Eledon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 192K n/a n/a n/a 560K n/a n/a n/a n/a n/a n/a n/a 120.00 n/a n/a n/a
Cost of Revenue
n/a n/a n/a 97K 95K 94K 94K 94K 92K 93K 93K 94K 93K 61K 44K 44K 46K
Gross Profit
n/a 192K n/a -97K -95K 466K -94K -94K -92K -93K -93K -94K -93K -60.88K -44K -44K -46K
Operating Income
-17.96M -24.5M -20.51M -14.5M -10.87M -10.34M -11.2M -10.35M -11.11M -58.69M -10.6M -9.28M -9.86M -9.38M -10.51M -7.97M -9.01M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.5M -44.19M 76.97M -44.91M -10.29M -9.63M -10.35M -9.58M -10.77M -58.38M -10.47M -9.25M -9.86M -9.38M -10.5M -7.97M -9M
Net Income
-6.5M -44.62M 76.97M -44.91M -10.29M -9.63M -10.35M -9.58M -10.43M -58.05M -10.34M -9.21M -9.87M -8.81M -9.82M -7.38M -8.5M
Selling & General & Admin
4.43M 6.77M 3.99M 4.4M 3.36M 3.18M 3.27M 3.15M 3M 2.79M 3.15M 3.54M 3.22M 3.2M 2.85M 3.73M 3.35M
Research & Development
13.53M 17.93M 16.52M 10.11M 7.41M 7.07M 7.93M 7.2M 8.11M 7.25M 7.45M 5.74M 6.63M 6.18M 7.66M 4.24M 5.65M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 36K -5K n/a 3K -1K 5K
Operating Expenses
17.96M 24.7M 20.51M 14.5M 10.77M 10.24M 11.2M 10.35M 11.11M 10.04M 10.6M 9.28M 9.86M 9.38M 10.51M 7.97M 9.01M
Interest Expense
n/a n/a n/a n/a n/a 338K n/a n/a n/a n/a n/a n/a 5K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -95K -94K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 24.7M 20.51M 14.5M 10.87M 10.34M 11.2M 10.35M 11.11M 10.04M 10.6M 9.28M 9.86M 9.38M 10.51M 7.97M 9.01M
Income Tax Expense
n/a -431K n/a n/a 51.72K 50.19K n/a -28.09K -338K -335K -127K -36K 5K -579K -686K -588K -501K
Shares Outstanding (Basic)
77.13M 59.79M 51.95M 42.28M 29.99M 24.21M 29.97M 24.01M 14.29M 13.78M 14.27M 14.27M 14.33M 14.31M 14.82M 14.82M 14.83M
Shares Outstanding (Diluted)
771.27M 59.79M 55.48M 42.28M 29.99M 24.21M 29.97M 24.01M 14.29M 13.78M 14.27M 14.27M 14.33M 14.82M 14.82M 14.82M 14.83M
EPS (Basic)
-0.08 1.04 -0.34 -1.06 -0.34 -0.4 -0.35 -0.4 -0.73 -4.21 -0.73 -0.65 -0.69 -0.62 -0.66 -0.5 -0.57
EPS (Diluted)
-0.08 0.10 -0.32 -1.06 -0.34 -0.4 -0.35 -0.4 -0.73 -4.21 -0.73 -0.65 -0.69 -0.59 -0.66 -0.5 -0.57
EBITDA
-17.96M -24.61M -20.43M -14.4M -10.77M -10.24M -11.1M -10.26M -11.02M -9.95M -10.51M -9.19M -9.77M -9.32M -10.46M -7.93M -8.96M
EBIT
n/a -24.7M -20.51M -14.5M -10.87M -10.34M -11.2M -10.35M -11.11M -10.04M -10.6M -9.28M -9.86M -9.38M -10.51M -7.97M -9.01M
Depreciation & Amortization
n/a 88K 79K 97K 95K 94K 94K 94K 92K 93K 93K 94K 93K 61K 44K 44K 46K